Early use of high|efficacy disease‑modifying therapies makes the ...

Initial disease-modifying therapy for relapsing-remitting multiple ...

The initial treatment of relapsing-remitting multiple sclerosis (RRMS) with disease-modifying therapies (DMTs) is reviewed here. Switching DMT ...

(PDF) Correction to: Early use of high-efficacy disease-modifying ...

Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion.

High-Efficacy Disease-Modifying Therapies for Multiple Sclerosis

Abby Rogers, DMSc, PA-C, MPAS: Absolutely. So, early intervention in the disease of MS can really alter the disease course for patients. So ...

Disease Modifying Therapies For MS - DMTs

Sometimes you'll hear them called 'disease modifying drugs' (DMDs). A DMT could also be a treatment that uses stem cells. A DMT isn't a cure, but it could make ...

Sequencing of high-efficacy disease-modifying therapies in multiple ...

Currently available disease-modifying therapies (DMTs) for relapsing MS have been demonstrated to reduce disease activity, however most patients require a ...

Early and unrestricted access to high-efficacy disease-modifying ...

AbstractEarly intervention with high-efficacy disease-modifying therapy (HE DMT) ... Early use of high-efficacy disease‑modifying therapies makes the difference in ...

Association of Initial Disease-Modifying Therapy With Later ...

Multiple sclerosis (MS) is among the most common causes of disability in young adults. Eighty-five percent of patients present with the ...

Recent trends in disease-modifying therapy use and associated ...

Using sequence analysis, this study showed recent DMT use trajectories among PwMS where initiation of high-efficacy DMTs has become more common.

Early High-efficacy Therapies May Be Better to Eliminate MS Activity

Using high-efficacy MS therapies as a first treatment is more likely to eliminate disease activity compared to moderately efficacious ...

Does initial high efficacy therapy in multiple sclerosis surpass ...

Background: In relapsing-remitting multiple sclerosis (RRMS) the most common treatment strategy has been to start with low-moderate efficacy disease modifying ...

Timing of high-efficacy therapy for multiple sclerosis - The Lancet

High-efficacy therapies in multiple sclerosis are traditionally used after unsuccessful treatment with first-line disease modifying therapies.

Evidence for the benefit of early treatment in MS – what's new?

Switching from a medium- to a high-efficacy disease-modifying therapy (DMT) reduced the risk of a further early relapse, compared with switching to another ...

PND1 IMPACT of EARLY Disease Modifying Therapy (DMT ...

PND1 IMPACT of EARLY Disease Modifying Therapy (DMT) Treatment Initiation and Use of High-Efficacy (HET) on Clinical and Health Outcomes in Patients with ...

Early use of high-efficacy therapies in multiple sclerosis in ... - OUCI

Early intervention with high-efficacy therapies (HETs) is increasingly recognized as the best strategy to delay or mitigate disease progression from the ...

Early initiation of high-efficacy DMTs in MS - VJNeurology

Massimo Filippi, MD, Vita-Salute San Raffaele University, Milan, Italy, shares his perspective on using high-efficacy disease-modifying therapies (DMts) at ...

Switching Disease Modifying Therapies in Multiple Sclerosis

Obtaining MRI too early after switching therapy can confound efficacy evaluation of the new therapy. New lesion detected before the drug becomes fully active ...

High-efficacy Therapies for relapsing-remitting Multiple Sclerosis

An increase in the number of high-efficacy disease modifying drugs (DMDs) has both improved and complicated the management of relapsing- ...

Debate: Patients on low-efficacy DMTs should be…

“First and foremost, early treatment with high-efficacy DMTs has the best outcomes,” she said. Yet despite the “mounting evidence” supporting ...

Efficacy classification of modern therapies in multiple sclerosis

There are many disease-modifying therapies (DMTs) indicated for patients with RMS/RRMS, the earliest of which was IFN-β-1b. Most MS ...

Disease modifying drugs (DMDs) - MS Trust

Most DMDs are for people with relapsing remitting MS (RRMS), but there are some that are licenced for use by people with progressive MS. For ...